Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
AstraZeneca, breast cancer and Daiichi Sankyo
AstraZeneca, Daiichi Sankyo win first U.S. approval for key cancer drug
A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the closely watched treatment.
US FDA approves AstraZeneca's drug for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday.
Daiichi Sankyo Shares Jump After U.S. FDA Approves Breast Cancer Drug
Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday after rising as much as 9.7% earlier. Over the past three years, the stock posted a daily gain of more than 8% only four times.
AstraZeneca And Daiichi Sankyo's Datroway Gets US Approval For Metastatic HR+ Breast Cancer
British drug maker AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyo (DSKYF.PK) announced Monday that their Datroway (datopotamab
AstraZeneca Secures FDA Nod for New ADC Drug Datroway in Breast Cancer
AstraZeneca AZN announced that the FDA has approved its antibody-drug conjugate (ADC), datopotamab deruxtecan (or Dato-DXd), in patients with a certain type of breast cancer. The drug, developed in partnership with Japan-based Daiichi Sankyo,
5d
on MSN
FDA bans red food dye due to potential cancer risk
The U.S. Food and Drug Administration has officially banned red dye — called Red 3, or Erythrosine — from foods, dietary ...
Smithsonian Magazine on MSN
3d
FDA Bans Red Dye No. 3 From Food, Beverages and Ingested Drugs, Citing Link to Cancer in Lab Rats
After decades of debate, the Food and Drug Administration (FDA) has announced a ban on Red Dye No. 3, a synthetic food ...
JD Supra
3h
FDA Bans the Use of Red No. 3 in Food and Ingested Drugs
On January 16, the U.S. Food and Drug Administration (FDA) announced that it is revoking the authorization for use of FD&C Red No. 3 in ...
5d
on MSN
US FDA bans artificial food color Red No. 3 on links to cancer in rats
The U.S. Food and Drug Administration on Wednesday banned the use of Red No. 3, a synthetic food dye that gives some candies, ...
5d
on MSN
Cancer risk prompts FDA ban on red food dye
On Wednesday, the Food and Drug Administration (FDA) issued an order that will ban Red No. 3, a synthetic dye, from food, ...
Health on MSN
4d
FDA Bans Red Dye No. 3 in Food—Over 30 Years After It Was Linked to Cancer in Rats
The FDA has banned red dye No. 3 in food and ingested drugs, the agency announced. But what exactly is red dye No. 3, and why ...
7h
Fact Check: Rise in under-50s cancer diagnoses predates COVID-19 vaccines
Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining ...
4d
on MSN
How food brands and drugmakers are responding to FDA's ban of food dye Red 3
Companies say they are working to update their products to comply with the Food and Drug Administration's decision Wednesday to ban the artificial food dye Red 3, after the agency said it was revoking ...
abcnews4
4d
FDA bans Red 3 dye in food, drink and medicine due to cancer risk
Already banned in cosmetics and topical medicines since 1990, the Food and Drug Administration announced on Wednesday that ...
ThePrint on MSN
8h
2nd ‘living drug’ against blood cancer gets regulatory nod. All about Qartemi, made in India
Therapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback